Table. Core indicators for the World Health Organization’s monitoring and evaluation framework for hepatitis B and hepatitis C virus elimination 2016–2021.
Indicator number | Indicator name |
---|---|
C1 | Prevalence of chronic HBV and HCV infection |
C2 | Infrastructure for HBV and HCV testing |
C3 | a. Coverage of timely hepatitis B vaccine birth dose (within 24 hours) and other interventions to prevent mother-to-child transmission of HBV b. Coverage of third-dose hepatitis B vaccine among infants |
C4 | Needle–syringe distribution |
C5 | Facility level injection safety |
C6 | People living with HCV and/or HBV diagnosed |
C7 | a. Treatment coverage for hepatitis B patients b. Treatment initiation for hepatitis C patients |
C8 | a. Viral suppression for chronic hepatitis B patients treated b. Cure for chronic hepatitis C patients treated |
C9 | a. Cumulated incidence of HBV infection in children 5 years of age b. Incidence of HCV infection |
C10 | Deaths from hepatocellular carcinoma, cirrhosis and liver diseases attributable to HBV and HCV infection |
HBV: hepatitis B virus; HCV: hepatitis C virus.
Source: [6].